South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...

More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

The "miracle tool" HIV medicine lenacapavir will be sold in South Africa from as early as March or April 2026 according to ...

Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...

The US Department of State has announced a life-saving development to bring US-based Gilead Sciences’ breakthrough drug ...

Supporting global efforts to end AIDS by 2032 through the introduction of lenacapavir as a game-changing HIV prevention tool ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

The United States has suspended some funding for its flagship AIDS relief program, according to international organizations ...

As a child in her native Jamaica, Cheryl Smith watched her grandmother treat people as a natural healer and deliver most of ...

Community advocates, health providers and local leaders in Charleston are all joining forces Wednesday in observance of ...

Each year on Oct. 15, communities across the United States observe National Latinx HIV/AIDS Awareness Day (NLAAD), a day ...